Real World Data (Rwd) Treatment Patterns And Sequencing Of Patients With Multiple Myeloma (Mm)

Introduction: Despite advances in treatment, MM remains an incurable disease. RWD are key to improving our understanding of treatment patterns for patients with MM. This study examined the proportion of patients with MM (1) treated with an immunomodulatory drug (IMiD), a proteasome inhibitor (PI), an anti-CD38 monoclonal antibody (aCD38), or Other in first line (1L) through fourth line or greater (4L+) by calendar year; and (2) who had a change in treatment regimen at line change. Subgroup analyses were performed by cytogenetic risk status (high vs. standard), stem cell transplant (SCT) eligibility (eligible vs. ineligible), and practice type (community vs. academic).